EBV/KSHV-ASSOCIATED LYMPHOMAS

Clinical trials for EBV/KSHV-ASSOCIATED LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new EBV/KSHV-ASSOCIATED LYMPHOMAS trials appear

Sign up with your email to follow new studies for EBV/KSHV-ASSOCIATED LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test new drug duo to fight Virus-Driven cancers

Disease control Recruiting now

This early-stage study aims to find a safe dose of two drugs, pomalidomide and nivolumab, for adults whose cancers are caused by viruses. It is for people with cancers like Kaposi sarcoma, certain lymphomas, and HPV-linked cancers that have not responded to standard treatments. T…

Matched conditions: EBV/KSHV-ASSOCIATED LYMPHOMAS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

EBV/KSHV-ASSOCIATED LYMPHOMAS

Get alerted when new EBV/KSHV-ASSOCIATED LYMPHOMAS trials appear

Scientists test new drug duo to fight Virus-Driven cancers